
1. j immunol res. 2016;2016:3890306. epub 2016 sep 6.

study soluble hla-g congenital human cytomegalovirus infection.

rizzo r(1), gabrielli l(2), bortolotti d(1), gentili v(1), piccirilli g(2),
chiereghin a(2), pavia c(2), bolzani s(1), guerra b(3), simonazzi g(3), cervi
f(3), capretti mg(4), fainardi e(5), luca dd(1), landini mp(6), lazzarotto t(6).

author information: 
(1)department medical sciences, section microbiology medical genetics, 
university ferrara, ferrara, italy.
(2)operative unit clinical microbiology, st. orsola-malpighi university
hospital, bologna, italy.
(3)operative unit obstetrics prenatal medicine, department medical 
surgical sciences, st. orsola-malpighi university hospital, university of
bologna, bologna, italy.
(4)operative unit neonatology, st. orsola-malpighi university hospital,
bologna, italy.
(5)operative unit neuroradiology, careggi university hospital, firenze, italy.
(6)operative unit clinical microbiology, department specialised,
experimental, diagnostic medicine, st. orsola-malpighi university hospital,
university bologna, bologna, italy.

human leukocyte antigen-g (hla-g) nonclassical hla class antigen is
expressed pregnancy contributing maternal-fetal tolerance. hla-g be
expressed membrane-bound soluble forms. hla-g expression increases
strongly viral infections congenital human cytomegalovirus (hcmv) 
infections, functional consequences immunoregulation. work we
investigated expression soluble (s)hla-g beta-2 microglobulin
(component hla) molecules correlation risk transmission and
severity congenital hcmv infection. analyzed 182 blood samples 130
pregnant women 52 nonpregnant women 56 amniotic fluid samples women 
experiencing primary hcmv infection. median levels shla-g maternal
serum women primary hcmv infection higher comparison with
nonprimary uninfected pregnant women (p < 0.001). af hcmv symptomatic
fetuses presented higher shla-g levels comparison infected asymptomatic
fetuses (p < 0.001), presence hla-g free-heavy chain, concentration
gradient amniotic fluid maternal blood. significant statistical
difference beta-2 microglobulin median levels observed all
different groups. results suggest determination shla-g molecules in
both maternal blood amniotic fluid promising biomarker diagnosis of
maternal hcmv primary infection fetal hcmv disease.

doi: 10.1155/2016/3890306 
pmcid: pmc5029053
pmid: 27699182  [indexed medline]

